Viva · Specialty

Breast Viva Questions

Oral-exam style questions and answers on breast for MD, DNB and super-specialty practical examinations. Each answer links back to the playbook or Library entry it was written from.

What is the purpose of the BI-RADS assessment categories?
They provide a standardised final breast imaging assessment linked to malignancy likelihood and an appropriate management recommendation.

BI-RADS Assessment Categories

Enumerate the BI-RADS final assessment categories.
Category 0 is incomplete; 1 negative; 2 benign; 3 probably benign; 4 suspicious; 5 highly suggestive of malignancy; and 6 known biopsy-proven malignancy.

BI-RADS Assessment Categories

What does BI-RADS category 0 mean?
The assessment is incomplete because additional imaging evaluation and/or comparison with prior examinations is required before assigning a final category.

BI-RADS Assessment Categories

What is the malignancy likelihood and management of BI-RADS category 3?
The likelihood of malignancy is greater than 0% but no more than 2%. Short-interval imaging follow-up is recommended after a complete diagnostic evaluation.

BI-RADS Assessment Categories

How is BI-RADS category 4 subdivided?
Category 4A represents greater than 2% to 10% risk, 4B greater than 10% to 50%, and 4C greater than 50% but less than 95%. Tissue diagnosis should be considered for all three.

BI-RADS Assessment Categories

What distinguishes BI-RADS category 5 from category 4C?
Category 5 has at least a 95% likelihood of malignancy and imaging features highly suggestive of cancer, whereas category 4C remains below 95% despite high suspicion.

BI-RADS Assessment Categories

What is the essential requirement for assigning BI-RADS category 6?
The malignancy must already have been confirmed histologically, and the imaging must be performed before definitive treatment.

BI-RADS Assessment Categories

What is a common misuse of BI-RADS category 3?
Using it for an incompletely evaluated or indeterminate finding. Category 3 is restricted to appropriately characterised probably benign findings with a malignancy likelihood of no more than 2%.

BI-RADS Assessment Categories

More viva questions